X-ZELL

About:

Enabling same-day cancer diagnostics from minimally invasive samples

Twitter/X: xzellinc

Top Investors: Y Combinator, Essex Bio-Technology, Paul Buchheit, DIAG Deutsche Industrieanlagen, Feng Hu

Description:

X-ZELL is an award-winning medical technology company founded by Y Combinator alumnus, Dr Sebastian Bhakdi. We develop innovative laboratory solutions that enable same-day cancer diagnoses from minimally invasive sample material – we call it next-generation cytology (NGC).

Total Funding Amount:

$5.56M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2014-12-01

Contact Email:

info(AT)x-zell.com

Founders:

Sebastian Chakrit Punyaratabandhu Bhakdi

Number of Employees:

11-50

Last Funding Date:

2018-05-01

IPO Status:

Private

Industries: